OOIR: Observatory of International Research

Papers

(The H4-Index of Research and Practice in Thrombosis and Haemostasis is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Risk of venous thromboembolism in patients with COVID‐19: A systematic review and meta‐analysis	341
A proposal for staging COVID‐19 coagulopathy	76
Venous thromboembolism in critically Ill patients with COVID‐19: Results of a screening study for deep vein thrombosis	73
Prothrombotic changes in patients with COVID‐19 are associated with disease severity and mortality	65
Direct oral anticoagulants compared to low‐molecular‐weight heparin for the treatment of cancer‐associated thrombosis: Updated systematic review and meta‐analysis of randomized controlled trials	61
Vaccine‐induced Immune Thrombocytopenia and Thrombosis (VITT)	58
Using heparin molecules to manage COVID‐2019	55
Increased risk of thrombotic events in cold agglutinin disease: A 10‐year retrospective analysis	53
Sexism in the management of bleeding disorders	49
Heparin‐induced thrombocytopenia with thrombosis in COVID‐19 adult respiratory distress syndrome	47
Thrombosis and coagulopathy in COVID‐19: An illustrated review	46
Tranexamic acid evidence and controversies: An illustrated review	45
Risk of thrombotic complications in influenza versus COVID‐19 hospitalized patients	43
Emergence of institutional antithrombotic protocols for coronavirus 2019	39
What’s new in VTE risk and prevention in orthopedic surgery	38
Comparison of the coagulopathies associated with COVID‐19 and sepsis	38
Potential role of platelets in COVID‐19: Implications for thrombosis	38
Randomized trials of therapeutic heparin for COVID‐19: A meta‐analysis	37
Hematologic concerns in extracorporeal membrane oxygenation	36
Fibrinolytic therapy for refractory COVID‐19 acute respiratory distress syndrome: Scientific rationale and review	36
Abstract	36
Posters Abstracts	36
The Hemophilia Joint Health Score version 2.1 Validation in Adult Patients Study: A multicenter international study	35
Anticoagulation practice patterns in COVID‐19: A global survey	33
Essential aspects of the follow‐up after acute pulmonary embolism: An illustrated review	33

Abstracts	33
Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19	29
Protease‐activated receptors: An illustrated review	28
The contact activation system as a potential therapeutic target in patients with COVID‐19	28